A
Andreia Valente
Researcher at University of Lisbon
Publications - 54
Citations - 1439
Andreia Valente is an academic researcher from University of Lisbon. The author has contributed to research in topics: Ruthenium & Chain transfer. The author has an hindex of 20, co-authored 48 publications receiving 1190 citations. Previous affiliations of Andreia Valente include university of lille & Centre national de la recherche scientifique.
Papers
More filters
Journal ArticleDOI
Antitumour and Toxicity Evaluation of a Ru(II)-Cyclopentadienyl Complex in a Prostate Cancer Model by Imaging Tools
Lurdes Gano,Teresa Pinheiro,A. P. Alves de Matos,Francisco Tortosa,Tiago F. Jorge,Maria L. S. Gonçalves,Marta Martins,Tânia S. Morais,Andreia Valente,Ana Isabel Tomaz,Maria Helena Garcia,Fernanda Marques +11 more
TL;DR: Under the experimental conditions of this study, TM85 is less toxic than cisplatin, induces similar tumour reduction and avoids the formation of metastatic foci, and can be considered a valuable compound for further studies in the field of Ru-based anticancer drugs.
Journal ArticleDOI
Polymerization of ɛ-caprolactone using ruthenium(II) mixed metallocene catalysts and isopropyl alcohol: Living character and mechanistic study
Andreia Valente,Philippe Zinck,André Mortreux,Marc Visseaux,Paulo J. Mendes,Tiago J. L. Silva,Tiago J. L. Silva,M. Helena Garcia +7 more
TL;DR: In this paper, a series of ruthenium(II) complexes with the general formula [Ru(η 5 -C 5 H 5 ) (η 6 -substituted arene)] + [PF 6 ] − (substitized arene = 2-phenylpyridine (1), dibenzosuberone (2 ) and toluene (3 )), in combination with isopropyl alcohol, were used for the polymerization of ǫ-caprolactone.
Journal ArticleDOI
Half-lanthanidocenes catalysts via the “borohydride/alkyl” route: A simple approach of ligand screening for the controlled polymerization of styrene
TL;DR: In this article, the influence of the nature of several ligands on the performance of half-lanthanidocene catalysts was investigated using an in situ approach, with trends corresponding to those obtained starting from isolated precursors.
Journal ArticleDOI
Heteroleptic enantiopure Pd(II)-complexes derived from halogen-substituted Schiff bases and 2-picolylamine: synthesis, experimental and computational characterization and investigation of the influence of chirality and halogen atoms on the anticancer activity
Nazanin Kordestani,Hadi Amiri Rudbari,Isabel Correia,Andreia Valente,Leonor Côrte-Real,Mohammad Khairul Islam,Nicola Micale,Jason D. Braun,David E. Herbert,Nikolay Tumanov,Johan Wouters,Mohammed Enamullah +11 more
TL;DR: In this article, enantiomeric pairs of palladium complexes were synthesized by the reaction of enantiopure halogen-substituted Schiff bases (R or S)-N-1-(phenyl)ethyl-2,4-X1,X2-salicylaldimine with [Pd(pic)Cl2] (pic = 2-picolylamine).
Book ChapterDOI
Ruthenium and iron metallodrugs: new inorganic and organometallic complexes as prospective anticancer agents
Andreia Valente,Tânia S. Morais,Ricardo G. Teixeira,Cristina P. Matos,Ana Isabel Tomaz,M. Helena Garcia +5 more
TL;DR: An overview of the development of ruthenium and iron-based metallodrugs as prospective chemotherapeutics in cancer treatment can be found in this article, where the authors provide an overview of recent developments in this field.